1. Home
  2. CNXC vs FTRE Comparison

CNXC vs FTRE Comparison

Compare CNXC & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concentrix Corporation

CNXC

Concentrix Corporation

HOLD

Current Price

$28.46

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$17.46

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXC
FTRE
Founded
1991
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
CNXC
FTRE
Price
$28.46
$17.46
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$54.80
$14.06
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
03-24-2026
05-05-2026
Dividend Yield
5.79%
N/A
EPS Growth
N/A
N/A
EPS
1.20
N/A
Revenue
$9,825,771,000.00
$2,723,400,000.00
Revenue This Year
$5.29
N/A
Revenue Next Year
$2.49
$3.09
P/E Ratio
$26.80
N/A
Revenue Growth
2.15
1.00
52 Week Low
$19.12
$8.31
52 Week High
$57.88
$21.39

Technical Indicators

Market Signals
Indicator
CNXC
FTRE
Relative Strength Index (RSI) 52.99 43.25
Support Level $21.11 $16.92
Resistance Level $30.24 $18.13
Average True Range (ATR) 2.03 0.78
MACD 0.36 -0.10
Stochastic Oscillator 47.11 23.99

Price Performance

Historical Comparison
CNXC
FTRE

About CNXC Concentrix Corporation

Concentrix Corp is a technology and services company. It designs, implements, and manages end-to-end solutions, including customer experience process optimization, technology development and design engineering, front- and back-office automation, analytics, and business transformation services. The company serves clients across multiple industry verticals, helping them manage customer engagement and operational processes throughout the customer lifecycle. The company operates in a single operating segment. It generates revenue through the provision of technology and services under contractual arrangements. Geographically, the company generates the maximum revenue from the Philippines and the rest from India, the United States, Great Britain, Germany, Canada and Other countries.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: